Bellerophon Therapeutics is a clinical-stage biotherapeutics company. We are focused on developing innovative therapies in the treatment of cardiopulmonary diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. More … Continued
Location: United States, Warren

Investors 2

Mentions in press and media 1

02.04.2020ARCH Ventu...ARCH said it would use its two...--medcitynew...